logoslogan
Research

VIENNA ANNUAL MEETING

New priorities in fertility research

Vienna session organised by a 'priority setting partnership' for infertility unveils ten priorities for research in the four key areas: male infertility, female and unexplained infertility, assisted reproduction and the ethics of treatment.

VIENNA ANNUAL MEETING

'Core outcome measures' for improving the reliability of fertility trials

Substantial heterogeneity exists in the reporting of outcomes of fertility trials, with inconsistencies in numerators, denominators and definitions making results difficult to interpret, compare and combine in meta-analyses. Jack Wilkinson presented the rationale for a core outcome set of measures for fertility trials on behalf of the Cochrane Gynaecology and Fertility Group and the COMMIT initiative in Vienna.

VIENNA ANNUAL MEETING

Still a gap between hype and science in PGT-A

The benefits are being exaggerated and the costs underestimated by those promoting aneuploidy testing to clinics and patients. An exchange session with the ASRM urges caution.

VIENNA ANNUAL MEETING

No substitute for the randomised trial

Professor Rick Legro, a tireless advocate of randomised trials, talks to Focus on Reproduction about the general quality of evidence in reproductive medicine today - but with a particular reference to the latest international guidelines on PCOS.

ExCo19

2019 ANNUAL ASSEMBLY OF MEMBERS

Minutes of the Annual Assembly of Members held in Vienna

Minutes of the Annual Assembly of Members, held on Tuesday 25 June 2019, 18.00, at Messe Wien, Vienna, Austria

VIENNA ANNUAL MEETING

Still caution over the prognostic value of testing for sperm DNA damage

Conventional semen analysis according to WHO manual parameters is limited, with no consideration of testis function or sperm quality. Madelon Van Wely of the Academic Medical Centre University of Amsterdam reviewed current evidence in support of sperm DNA fragmentation testing in ART.

Farquhar

VIENNA ANNUAL MEETING

The prospect of consistent outcome measures in fertility studies

Goodbye to PR per ET? Professor Cindy Farquhar from the Cochrane Fertility & Gynecology group on plans to improve the quality of evidence in reproductive medicine and introduce core outcome measures of live birth in adequately powered studies.

EIM CONSORTIUM

The challenges of registry data for a new Chair of the EIM Consortium

It's now 20 years since ESHRE European IVF Monitoring (EIM) Consortium was founded, with activity data for 1997 as its first publication. Since then the Consortium's annual reports have been some of the most widely cited in Human Reproduction, and today providing more than a mere snapshot of what's going on. In Vienna Christine Wyns, head of gynecology and andrology at the Cliniques Universitaires Saint-Luc and Professor at the Catholic University of Louvain in Brussels, took over as Chair of the Consortium.

VIENNA ANNUAL MEETING

Fertility treatment not associated with added long-term risk of ovarian cancer

There is now a long catalogue of inconclusive studies investigating an association between ART and risk of ovarian cancer. A large-scale multicentre analysis reported in Vienna concluded that nulliparity rather than ART is the likely explanation for any link. Results were described as 'reassuring'.

VIENNA ANNUAL MEETING

Science hyped by the claims of journalism and marketing

Fertility as much as any other discipline in medicine is subject to over-exaggerated claims of popular reporting. Scientists should take care how they present their data.